MarketBeat
18 Aug 2026, 06:04 UTC · 6w ago
Verdict
Headline takes no side. We score TNDM +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Tandem is shifting international markets from distributor arrangements to direct sales, which has resulted in at least a 30% increase in selling prices per market.
So whatDirect sales significantly improve margins through higher pricing and better control over patient renewals and volume.
More positive than 93% of claims this week
Tandem has filed for FDA clearance of a tubeless version of the Mobi pump, targeting a market segment where the company has not historically competed.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 87% of claims this week
The company is transitioning to a pharmacy distribution model in the U.S. to eliminate high upfront DME costs, with a goal of moving 80% of pumps through this channel in 2-3 years.
So whatReducing out-of-pocket barriers ($800-$1,000) is expected to accelerate adoption rates among insulin-dependent patients.
More positive than 79% of claims this week
Tandem plans to begin a pivotal trial later this year for a fully closed-loop algorithm designed for both type 1 and type 2 diabetes patients.
More positive than 66% of claims this week
Management views GLP-1 medicines as complementary rather than competitive, noting that outcomes improve when used alongside automated insulin delivery.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company is expanding market access via pharmacy distribution, launching a new tubeless pump, and increasing margins through international direct sales.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
−25.8%
Price is moving against the score
$16.52 vs $22.26 close before publication (Aug 17) · not market-adjusted
TNDM chart →
